This Target Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday

-2.09%

-2.47%

-6.77%

-0.04%

+0.91%

Amphastar Pharmaceuticals, Inc. AMPH	24.81	-2.09%
DocGo Inc. - Common Stock DCGO	1.58	-2.47%
ModivCare Inc Ordinary Shares MODV	3.38	-6.77%
Target Corporation TGT	95.08	-0.04%
Warner Music Group WMG	26.58	+0.91%

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Canaccord Genuity analyst Richard Close downgraded DocGo Inc. (NASDAQ:DCGO) from Buy to Hold and lowered the price target from $5 to $1.45. DocGo shares closed at $1.40 on Friday. See how other analysts view this stock.
Barrington Research analyst Michael Petusky downgraded the rating for ModivCare Inc. (NASDAQ:MODV) from Outperform to Market Perform. ModivCare shares closed at $1.17 on Friday. See how other analysts view this stock.
JP Morgan analyst Ekaterina Knyazkova downgraded Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) from Overweight to Neutral and cut the price target from $45 to $30. Amphastar Pharma shares closed at $24.11 on Friday. See how other analysts view this stock.
Bernstein analyst Zhihan Ma downgraded the rating for Target Corporation (NYSE:TGT) from Market Perform to Underperform and lowered the price target from $97 to $82. Target shares closed at $96.40 on Friday. See how other analysts view this stock.
Goldman Sachs analyst Stephen Laszczyk downgraded Warner Music Group Corp. (NASDAQ:WMG) from Buy to Neutral and slashed the price target from $35 to $28. Warner Music shares closed at $27.36 on Friday. See how other analysts view this stock.

Considering buying TGT stock? Here’s what analysts think:

Read This Next:

5 Stock Picks Last Week From Wall Street’s Most Accurate Analysts

Photo via Shutterstock

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.